← FDA Drug Approvals (Drugs@FDA)

STRIBILD

NDA · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2012-08-27

Drug application

FDA Application #

NDA203100

Application type

New Drug Application

Brand name

STRIBILD

Generic name

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE

Active ingredients

COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GILEAD SCIENCES INC

Manufacturer

Gilead Sciences, Inc.

First approval

2012-08-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown